News Archives


May 05, 2011
ITSI BIOSCIENCE AWARDED SMALL BUSINESS EXPORTER OF THE YEAR

ITSI-Biosciences wins Small Business Exporter of the Year, and is being awarded by The Saint Francis University Small Business Center, Friday June 17th, 2011. This award recognizes the outstanding achievements of the Southern Alleghenies Region’s most successful entrepreneurs and small business advocates.


March 04, 2011
ITSI BIOSCIENCE FEATURED IN COMMERCIAL NEWS USA MAGAZINE: AMERICAN EXPORTERS

ITSI-Biosciences featured in Commercial News USA, the official export magazine of the U.S. Department of Commerce.

Commercial News USA is the premiere export promotion program for promoting U.S. goods and services in more than 178 countries around the world. The catalog-style magazine reaches more than a quarter million buyers and distributors worldwide. The magazine is direct-mailed to subscribers around the world, and also is distributed at U.S. embassies and consulates, as well as at major trade shows.

In addition to us being included in the print edition, we receive a free listing, email and Web links in both the pdf and html versions of the magazine on their Web site.

Click here to view advert


February 17, 2011
FUNAKOSHI WINS 2010 DISTRIBUTOR OF THE YEAR AWARD

Funakoshi Co., Ltd of Tokyo a leading distributor of bioreagents in Japan has been named the ITSI-Biosciences 2010 “Distributor of the Year”. This is the second time that Funakoshi is wining this distinguished and highly competitive award. Funakoshi Co., Ltd has continued to contribute to the growth of ITSI-Biosciences products in Japan.

Criteria for selecting the award winner included a) overall number of items ordered in 2010, b) frequency of order, c) the different types of products ordered d) communication of feedback from customers to ITSI-Biosciences. To win the award, a distributor must place first in at least three of the four categories. Funakoshi placed first in three categories and second in one category, outperforming other international distributors.

According to Dr Richard I. Somiari, President/CSO, “this unique partnership leverages Funakoshi and ITSI-Biosciences strengths to bring innovative life science products to scientists in Japan at a competitive price”. 

 “It is a great honor to receive this award. We really hope that ITSI-BIOSCIENCES will dramatically boost their market forces in 2011. Of course, we will also exert our utmost efforts to establish their market in our sales territory as before.” says Shinya Ichikawa, Marketing Specialist, and International Business Department at Funakoshi Company.

In appreciation of their efforts, Funakoshi Co. will receive an authentic 2010 Distributor of the Year award, a certificate and an additional 10% off on all orders placed with ITSI Biosciences during the month of March 2011.

Click here to view Award


December 7, 2010
Christopher P. Koop, from Congressman Mark Critz office visited ITSI-Biosciences

Mr. Koop toured the new state-of-the-art facility to learn more about ITSI’s business and operations in Johnstown. As Congressman Critz’s field representative Mr. Koop is helping ITSI-Biosciences establish strategic relationships, expand operations and take advantage of the unique opportunities for life science and biotechnology companies in the Johnstown area and 12th congressional district.


June 30, 2010
Visiting PhD Research Fellows commence Breast Cancer and Sickle Cell Research at ITSI-Biosciences

Two PhD Research Fellows from Olabisi Onabanjo University, Nigeria, arrived in Johnstown, PA today to commence research programing at ITSI – Biosciences. The two students will be in the United States for 6 months researching on Sickle Cells and Breast Cancer.

Picture Legend from the left: Mutu A. Alabi (Phd Research Fellow in Breast Cancer), Teresa Dugan (Consultant/Training Specialist) and Olaleken H. Oyefuga (Phd,Research Fellow in Sickle Cell)


 

July 28, 2010
President and Chief Executive Officer of Protein Discovery visits ITSI-biosciences

Chuck Witkowski founder of Protein Discovery visits ITSI-Biosciences facility today. Mr Witkowski is is a visionary leader with demonstrated expertise in building successful medical and life science companies from inception.

Picture Legend from the left: Dr. Richard Somiari (President & Chief Scientific Officer of ITSI-Biosciences), Chuck Witkowski (President & Chief Scientific Officer)


 

June 21, 2010
ITSI-Biosciences host summer interns

“ITSI – Biosciences host summer interns”. Five students will be at ITSI – Biosciences for 7 weeks as interns. Three are high school graduates; Nicole Danchanko that will be going to Penn Highlands Community College in the fall to study Biology, Richard Somiari Jr going to Lehigh University also in the fall to study Computer Engineering and Jamie Lepsch going to Robert Morris University to also study Computer Engineering. Two are college students; Zach Evans a sophomore from the George Washington University majoring in International Affairs, Jasmine LaRue majoring in Biology at Mount Aloysius College.


 

March 01, 2010
DHQ KMS personnel commence training in San Antonio

ITSI, LLC today announced the commencement of the second phase of the training for the visiting Nigerian Defence Headquarters (DHQ) Knowledge Management System (KMS) project personnel in San Antonio, TX.

This phase of the training is provided by BIF Technologies of San Antonio, TX. BIF is ITSI's technical partner for implementation and management of the DHQ-KMS program.


 

March 1, 2010
Nigerian Armed Forces DNA Bank and Analysis personnel visit Cybergenetics Corporation, Pittsburgh, PA
.

ITSIBIO today announced that ITSI Biosciences and Cybergenetics (www.cybgen.com) are collaborating to train the Nigerian Armed Forces DNA Bank (AFDB) personnel, and implement modern methods for forensic DNA analysis and interpretation in Nigeria. As part of this strategic relationship 6 AFDB personnel undergoing training at ITSI Biosciences since September 2009 have visited and trained at the CyberGenetics facility in Pittsburgh, PA from December 16th 17th, 2009. Cybergenetics is a leader in producing unique computational approaches for automating and simplifying forensic DNA data processing, analysis and interpretation. The Cybergenetics TrueAllele® system enables rapid and automated forensic DNA data analysis and interpretation.


 

February 17, 2010
2B Scientific, United Kingdom appointed distributor for Europe.

ITSIBIO has signed a representation and distribution agreement with 2B Scientific Limited, Upper Heyford, United Kingdom. 2B Scientific (www.2bscientific.com), a specialist reagents distribution company to the UK Life Science Markets will serve as a springboard for European markets. This appointment gives 2B Scientific the rights to promote, market, distribute and sell ITSIBIO products in Europe. Clients in this territory can now place orders for all ITSIBIO products through 2B Scientific.


February 4, 2010
Nigerian Defense Headquarters, ITSI - Biosciences representative visit Nigerian Armed Forces DNA Bank (AFDB) in Abuja, Nigeria.

ITSIBIO today announced that Nigerian Defence Headquarters Research and Development leaders, Major Gen BT Obasa (Chief, Research & Development) and Air Vice Marshall A Badeh (Director of Research) and Dr Richard I. Somiari (President & CSO) ITSI - Biosciences, LLC toured the Nigerian Armed Forces DNA Bank at Mogadishu Barracks, in Abuja, Nigeria. ITSI Biosciences is helping the Nigerian DHQ develop a Genvault technology based DNA bank capable of banking DNA from 100,000 military personnel. A total of 6 AFDB personnel are currently undergoing DNA banking and analysis training at ITSI Biosciences, Johnstown PA. As part of the training, the AFDB personnel have also spent time at Indiana University of Pennsylvania, Indiana, PA, Cybergenetics, Pittsburgh, US Armed Forces DNA Identification Laboratory (AFDIL), Rockville, MD. The visit was to assess the readiness of the facility to receive the trainees who will return to Nigeria in April 2010.

Picture Legend: Nigerian DHQ Research & Development leaders and ITSI representative visit the Armed Forces DNA bank in Abuja, Nigeria. From right: Maj Gen BT Obasa (Chief Research & Development, DHQ), Richard I. Somiari, PhD (President & CSO, ITSI Biosciences) and AVM Badeh (Director of Research, DHQ)


January 20, 2010
Nigerian Armed Forces DNA Bank (AFDB) personnel visit US Department of Defense AFDIL and AFRSSIR.

ITSIBIO today announced that 6 Nigerian AFDB personnel visited the United States Department of Defense (DoD) Armed Forces DNA Identification Laboratory (AFDIL; www.afip.org/consultation/AFMES/AFDIL/index.html) in Rockville, MD and Armed Forces Repository of Specimen Samples for the Identification of Remains (AFRSSIR; www.afip.org/consultation/AFMES/AFDIL/AFRSSIR/) in Gaithersburg, MD. The visit is part of the comprehensive forensics DNA banking and analysis training organized by ITSI Biosciences, Johnstown, PA for the Nigerian Armed Forces DNA Bank and Analysis personnel. The visit allowed the AFDB personnel to tour both facilities and observe first-hand how DNA is collected, stored at room-temperature and analyzed by the US military in support of military missions.


 

December 9, 2009
US Armed Forces DNA Identification Laboratory (AFDIL) Education team arrive Johnstown, PA to train Nigerian Armed Forces DNA Bank personnel.

ITSIBIO today announced that instructors from AFDIL based in Rockville, MD have arrived Johnstown, PA to help train Nigerian Armed Forces DNA Bank (AFDB) personnel. The AFDIL team led by Michael D. Coble, PhD (Research Section Chief) arrived in Johnstown, PA on the 8th of December 2009. According to Richard Somiari, PhD, President of ITSI, LLC “the training will focus on military applications and cover; 1) Forensic DNA Analysis 2) Short Tandem Repeat (STR) Data Analysis and Interpretation 3) Population Genetics and Statistics and 4) Non-STR DNA Markers. ITSI LLC (www.itsi.us; www.itsibio.com) is helping AFDB setup a state-of-the-art DNA banking and analysis center in Abuja, Nigeria that will be capable of banking DNA from up to 100,000 military personnel. The involvement of AFDIL in the training program is critically important and key to achieving the overall project goals added Dr Somiari.


 

December 7, 2009
Nigerian Defence Headquarters personnel commence computer science and Knowledge Management System training in Johnstown, PA.

ITSI, LLC today announced the arrival of 6 Nigerian Defence Headquarters (DHQ) personnel in Johnstown, PA to commence five months computer science and knowledge management system training. According to Richard I Somiari, President and CEO of ITSI, the training is part of the MOU between DHQ and ITSI concerned with the design, construction and setting up of a prototype knowledge management system for DHQ. Several organizations including Pennsylvania Highlands College, Johnstown PA; BIF Technologies, San Antonio, TX and ThreatGuard, San Antonio, TX have teamed up with ITSI, LLC to provide the training.


 

December 04, 2009
ITSI Biosciences is plea sed to announce the addition of Richard Cosgrove as Vice President of Operations and Business Development to the organization
.

Mr. Cosgrove will be directly responsible for all aspects of business development and marketing to help ITSI Biosciences expand its domestic and international market share in academic, corporate and government sectors, as well as managing operations of the company’s business units. According to Richard Somiari, PhD, President and CEO, “We are extremely pleased to have Rick join us at this important time in the growth of the company. Our future in the national and international market place is very bright, and Mr. Cosgrove will focus on consolidating existing markets and working to open up new business opportunities in government, the defense industry and pharmaceutical companies”.

Mr. Cosgrove comes with extensive marketing and management experience in the healthcare industry. He holds a Master's degree in Liberal Arts/International Studies from Lock Haven University, Advanced Graduate Studies International Business Management certificate from Point Park University and a Bachelor of Science degree, in Marketing from Indiana University of Pennsylvania. Rick has previously held positions at HealthSouth Corporation and University of Pittsburgh Medical Centers and is Adjunct Professor of Marketing/Management at the University of Pittsburgh at Johnstown. He is a member of the Board of Directors of the Greater Johnstown/Cambria County Chamber of Commerce, where he is the chairman, Government Action Committee. Mr. Cosgrove is a member of the I.U.P.  Eberly College of Business and Technology's business advisory board, Johnstown Symphony Orchestra's board of advisors and is chairman of the American Heart Association Cambria/Somerset Heart Ball 2010.


 

September 02, 2009
Armed Forces DNA Bank (AFDB) personnel commence DNA banking and analysis training at ITSI-Biosciences

Six members of the Nigerian Armed Forces DNA Bank (AFDB) representing the Army, Navy and Air force, arrived in Johnstown, PA today to commence DNA banking and analysis training at ITSI Biosciences. The team will be in the United States for 8 months learning new DNA banking and analysis methods. According to Richard Somiari, PhD, President of ITSI Biosciences, the training is part of the strategic relationship between ITSI Biosciences and the Nigerian Defense Headquarters concerned with the establishment of a state-of-the art DNA bank and analysis center for the Nigerian military. When fully implemented, the Nigerian Defence Headquarters DNA banking initiative which is the first military large-scale DNA banking initiative of its kind in Africa will have capacity to bank DNA from up to 100,000 military personnel.

AFDB Personnel: Abiodun Ebenezer Adebiyi(Lt. Col, Army), Chidi Innocent Onuoha(L/Cpl, Army), Olarewaju Anthony Ogundele(PO Navy), Anthony Friday Akpan(FS, Air Force), Ikwoegbu Mba Igbe(Sqn. Ldr, Air Force), Livinus Ukachukwu(Lt. Cdr. Navy).


February 1, 2009
ITSI Biosciences moves into new larger facility with ISO Certified Clean Room

ITSIBIO today announced its movement into its new and larger facility. The new state-of-the-art facility in the Kernville district of Johnstown, PA is a green building with a silver status. The new facility includes more office space, expanded research laboratory and kit manufacturing space, and an ISO Certified Class 1000 clean room. This move is another step in our company's growth strategy states Richard Somiari, PhD, founder and president of ITSI Biosciences. ITSIBio continues to be successful in delivering innovative services, developing easy-to-use sample preparation kits and securing competitive grants for cancer biomarker development.

 


 

January 19, 2009
ITSI Biosciences launches packaging for ITSIPrep products

ITSIBIO today announced the introduction of a new and improved packaging for its distinctive line of ITSIPrep products. The new colorful and distinctive packaging is a marketing tool that reflects the key attributes of ITSIPrep line of products. This new packaging replaces the plain white package that the company has been using for three years. According to Richard Somiari, PhD, President of ITSI Biosciences this new package will distinguish ITSI Biosciences products, and provide better protection to the contents during shipment of our innovative products to customers in the USA and around the world.

 


 

January 5, 2009
ITSI Biosciences is a subrecipient of a 5 year $2 million RO1 grant to study prostate cancer

ITSI Bioscience has announced that it is a Subrecipient of a $2 million 5 year RO1 grant awarded to Dr Karam El-Bayoumy of Penn State University Cancer Center. This NCI subaward will fund proteomics research at ITSI Biosciences, focusing on the identification of biomarkers of prostate cancer risk. Specifically, ITSIBio will utilize high performance 2D-DIGE MS and nano-LC/MS/MS to identify and characterize redox-sensitive proteins, and global proteomic patterns associated with the form and dose of selenium administered to human subjects, and those associated with the age of the subjects.


 

December, 2008
New lab, NCI funding provide ITSI-Biosciences with broader base for new breast-cancer detection test

Dr. Richard Somiari, the founder of ITSI Biosciences, a life-science enterprise in the Johnstown region, is preparing to move his company into its new headquarters by year's end--just in time to expand field investigations of a blood-sampling method that promises to increase the speed and lower the cost for early detection of breast cancer. That work received a $100,000 Small Business Innovation Phase I Research Grant from the National Cancer Institute in July.

After what appears to be a long search for the right space, ITSI-Bio's third move promises to be a charm for a four-year-old business that represents a bellwether for the efforts to attract a cluster of life-science enterprises to the Johnstown region.

"We've been carrying on our work in about 1,500 square feet and need the flexibility of a custom-built laboratory," Somiari says from his present location in the Kernville neighborhood of Johnstown, Cambria County. The new location will place the company, which provides analytical services and sampling kits for bioscience laboratories worldwide, in a 10,000-square-foot facility nearer the heart of Johnstown.

ITSI-Bio will initially occupy half of that area, where it will be able to broaden its basic analytical services to bioscience researchers. In addition to analytics, the company also offers kits for isolating, handling, testing, and monitoring proteins, as well as reagents used to tag biochemical reactions. "That business has kept the doors open while we have pursued our method for early breast cancer detection," Somiari says.

The detection protocol draws upon about 20 biological markers, some of which have been clearly associated with breast cancer and others that Somiari has identified for the blood-sample analysis that he hopes to demonstrate as a faster and more precise testing method.

While that goal has directed his passion as a scientist, he has been closely identified with the future of biotech in Johnstown. He came to the region from the University of Maryland in 2000 to start the Windber Research Institute, the region's first biomedical research institute. Only later did he form his own company to develop a commercial product--deciding, as he says, that it would be a good idea to practice the entrepreneurship that he had been preaching.

The NCI grant will finance expansion of the breast-cancer-test sampling and independent validations of results through UPMC McGee Hospital, Indiana Regional Medical Center, and the Department of Biomedical Informatics at the University of Pittsburgh. It will also support the development of algorithms to analyze results, as well as development of a Phase II NCI grant for up to $1 million.

Source: ITSI-Biosciences, Richard I. Somiari
Writer: Joseph Plummer
Original Article: http://www.keystoneedge.com/innovationnews/itsibio1204.aspx


 

November, 2008
ITSI Biosciences receives $100,000 Phase 1 SBIR Grant from NCI for breast cancer research

ITSI – Bioscience www.itsibio.com has announced the receipt of a $100,000 Small Business Innovation Research (SBIR) Phase 1 grant from the National Cancer Institute. The grant will support ITSIBIO's ongoing blood-based breast cancer detection biomarker program that promises to provide an alternate method for earlier detection and accurate classification of breast malignancies.  

At the moment mammography is the most widely used screening tool for breast disease detection and diagnosis. Unfortunately, mammography can miss some breast cancers, especially in young women with dense breast, it cannot unequivocally distinguish between benign and malignant lesions and it can not be performed remotely. If successfully validated, the proposed blood test would be beneficial to all women who show abnormalities in their mammograms and require further testing. Most of these women currently endure biopsies, up to 80% of which are probably unnecessary, as no cancer is found.

According to Richard Somiari, PhD principal investigator for the study titled "development of a blood test for breast cancer detection" the grant will support a) the collection of blood samples from informed and consented female donors, b) multiplexed assay development using a suspended array technology and c) development of a prototype breast disease classification model. While there are other efforts around the world to develop biomarker based tests for breast disease detection and classification the "ITSIBIO blood test is unique in its approach, because, it could allow accurate classification of breast disease and employ a reliable and sensitive blood RNA detection method that does not require RNA isolation and polymerase chain reaction" added Dr Somiari.


 

April, 2008
Life Sciences-Ltda of Sao Paulo, Brazil appointed exclusive distributor

ITSIBIO has signed a representation and distribution agreement with Life Sciences-Ltda (http://www.life-sciences.com.br), Sao Paulo, Brazil. This agreement, which is effective from March 14th 2008, gives Life Sciences exclusive rights to promote, market and distribute ITSIBIO products in Brazil. Clients in this territory can now place orders for all products through Life Sciences.


 

March, 2008
ITSIBIO signs distribution agreement with Precision Technologies PTE Ltd, Singapore

ITSIBIO has signed a representation and distribution agreement with Precision Technologies PTE Ltd, Singapore (www.pretech.com.sg). This agreement, which is effective March 17th 2008, gives Precision Technologies exclusive rights to promote, market and distribute ITSIBIO products in Singapore, Malaysia and Indonesia. Clients in this territory can now place orders for all ITSIBIO products through Precision Technologies. Orders can be place by Phone: +6273-4573, Fax 6273-8898 or E-mail: scitech@pretech.com.sg.


 

February, 2008
ITSIBio Facility Update

The new ITSIBio facility is to be completed in August 2008.


 

January, 2008
NCI extends Blanket Purchase Agreement with ITSIBIO to 2010.

NCI has extended the Blanket Purchase Agreement (BPA), originally signed with ITSIBIO in 2005, until 2010. This highly successful BPA which is managed by SAIC-Frederick, allows all NCI researchers to purchase genomics, proteomics and mass spectrometry services, and consumables from ITSIBIO at a pre-negotiated price. The BPA streamlines the process of outsourcing analytical support and locks-in lower prices for all investigators by leveraging economy of scale. Because the BPA contains legally binding confidentiality and non-disclosure clauses, researchers can fully discuss their experiments with the confidence that their ideas and scientific results will be safe and protected to the full extent required by law.

ITSIBIO receives Human Subject Research and ICH-GCP Certification.

ITSIBIO has received the Human Subject Research and International Conference on Harmonization (ICH) Good Clinical Practice (GCP) certifications. ICH-GCP brings together the regulatory authorities of Europe, Japan and the United States and experts from the pharmaceutical industry to ensure protection of human subjects and allow a more economical use of human, animal and material resources, and the elimination of unnecessary delay in the global development and availability of new medicines whilst maintaining safeguards on quality, safety and efficacy, and regulatory obligations to protect public health. ICH-GCP facilitates the dissemination and communication of information on harmonized guidelines, and the use such information/guidelines to encourage the implementation and integration of common standards. This significant milestone means that ITSIBIO's staffs have a working knowledge of the principles and ethics associated with good clinical practices, understands Good Clinical Practices dictated by FDA (http://www.fda.gov/oc/gcp/regulations.html) and the ICH Requirements for Sponsors, Monitors, and Investigators. ITSIBIO affirms that all projects performed at ITSIBIO will strictly adhere to Use of Human Subject Research and ICH-GCP guidelines to allow the submission of the data for regulatory approval. Both certifications were received through the Collaborative Institution Training Initiative (CITI, http://www.citiprogram.org/).

ITSIBIO signs agreement with BioConsult, Jerusalem, Israel.

ITSIBIO has appointed BioConsult, Jerusalem, Israel (http://www.bioconsult.co.il/ ) as the exclusive distributor and representative in Israel. The agreement signed December 2007, gives BioConsult exclusive rights to promote, market and distribute all ITSIBIO products and services in Israel. Clients in Israel can now place orders through BioConsult via phone or by visiting their website.

ITSIBIO signs collaboration agreement with University of the Western Cape, Bellville, South Africa.

ITSIBIO has signed a collaboration agreement with the University of Western Cape Proteomics Research Group. Under the agreement, signed December 2007, both parties will collaborate in the areas of proteomics and sample preparation reagent development.

ITSI-Biosciences signs collaboration and distribution agreement with Innovative Biotech Ltd, Keffi Nigeria.

ITSIBIO enters the Nigerian market by signing a collaboration agreement with Innovative Biotech Limited (IBL), Keffi, Nigeria (www.innovativebiotechng.com). Under the agreement signed November 2007, ITSIBIO and IBL will collaborate to develop diagnostic assays for infectious diseases of national interest to Nigeria and the West African region. A distribution agreement signed in December 2007 during the visit of Simon Agwale, PhD, IBL CEO, to ITSIBIO head office in Johnstown, PA also gives IBL the exclusive rights to market, distribute and support ITSIBIO, Panomics Inc. and GenVault Inc products and services in Nigeria. All orders in the Nigerian market should now be placed through IBL Nigeria.

Bin Ali Medical Supplies appointed distributor for the Middle East market.

ITSIBIO announced today the appointment of Bin Ali Medical Supplies (BAMS), Abu Dhabi, United Arab Emirates (http://www.binalimed.com/) as the exclusive distributor and representative in the Middle East. The agreement signed in October 2007, allows BAMS to promote, market and distribute all ITSIBIO's products and services in the Middle East. Clients in Middle East can now place orders through BAMS.


May, 2007

ITSIBIO enters the Indian market by signing an exclusive agreement with SR Biosytem of New Delhi. Under the agreement signed May 2007, SR Biosytem will promote, market and distribute all ITSIBIO's line of products, accessories and services in India. All orders in the Indian sub-continent should now be placed through SR Biosystem.


April, 2007

ITSI signs an exclusive agreement with Separation Scientific (SA) (PTY) Ltd, of South Africa. Under the agreement that is effective from April 2007, Separation Scientific will promote, market and distribute all ITSIBIO's products and services in the South Africa and other neighboring countries. Clients in Southern Africa should now place orders through Separation Scientific (SA) (PTY).


 

December 5 , 2006

Pennsylvania Governor Rendell announces the investment of $500,000 to enable ITSI to expand its research facility and operations.


 

September 28, 2006

ITSI representative invited to speak at the South African Bio2Biz International Biotechnology Conference, Durban, South Africa. A paper titled From Genomics and Proteomics to Bio-Business presented.


 

September 12, 2006

ITSI representative invited to speak at the International Symposium on Inflammation: An Underlying Factor in Several Diseases, Ibadan, Nigeria. A paper titled Role of Proteomics in Inflammation Research presented as a keynote lecture.


 

September 7, 2006

ITSI signs a collaboration agreement with the Advancement Center, College of Medicine, University of Nigeria. Under this agreement ITSI will work with the College of Medicine to develop integrated biomedical research programs and a biorepository to support cancer and complex disease research.


 

August 15, 2006

ITSI signs an exclusive Representative and Distributorship agreement with InterSciences Inc., Markham Ontario, Canada. Under this agreement, InterSciences will promote, market and distribute the ITSIPREP line of products and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay in Canada.


 

June 2006

Dr Munir O. Azeez (Col.) of the Nigerian Army Medical Corps (NAMC) joins ITSI for six months advanced biomedical research training, as part of the training and collaboration agreement between ITSI and NAMC. Dr Azeez is interested in applying advanced proteomic technologies to study tissue from patients diagnosed with temporo-mandibular joint disease.


May 2006

ITSI signs an exclusive distribution agreement with Funakoshi Japan. Funakoshi will promote, market and sell the ITSIPREP™ line of products in Japan.

www.funakoshi.co.jp


 

April 2006

ITSI signs a non-exclusive Sales Representative Agreement with Grace Scientific LLC, Clarksburg, MD, USA. Grace Scientific will promote, market and sell ITSI’s services, especially 2D-DIGE and 2D-Image analysis services and all the ITSIPREP™ line of products in the Maryland, Washington DC and Virginia area.


 

March 2006

ITSI signs an exclusive Representative and Distributorship agreement with Rainbow Biotechnology Co., Taipei, Taiwan. Rainbow will promote, market and distribute the ITSIPREP™ line of products including optimized and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay.

www.rainbowbiotech.com.tw


February 1 2006

Itsi-Biosciences has moved to a new, larger location. Images of our new facility and additional information will available online shortly. Please see the Contact page for our new address.


January 2006

ITSI appoints Syngenic Biotecnologia Ltda., Sao Paolo Brazil as the exclusive distributor of the ITSIPREP™ line of products in Brazil. The agreement, which was signed in October 2005, covers all the optimized and easy-to-use kits for protein isolation, protein fractionation, protein precipitation, albumin removal and protein assay.


November 24 2005

ITSI-Biosciences President and CSO Richard Somiari Ph.D. is prominently featured in the 11/24/05 issue of Nature.


 

September 14 2005

Itsibio represented at GE Healthcare 2D-DIGE Users Group meeting in Nashville, TN. Presents paper "Application of 2D-DIGE technology for the analysis of clinical specimens."


 

September 9 2005

Robin L. Fisher, Director Asia & Europe, International Business Development, PA DCED, Mr. Donald M. Bonk, International Trade Manager, SAPDC and Ms. Sushama A Kanetkar, Director, PA Trade Representative Office in India, and Supriya, Trade & Investment Advisor, PA Trade Office India visit Itsibio corporate headquarters/laboratory to discuss export opportunities and entry into the Indian market.


 

September 8 2005

ITSIBIO invited to exhibit products at the Cambria County Chamber of Commerce Small Business Expo in Ebensburg, PA


 

August 31 2005

Itsibio and Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil sign agreement to explore business opportunities of mutual interest involving proteomics, clinical research/trials, tissue repository development and management.

ITSIBIO representative met with Prof. Carlos Menke and staff of Hospital de Clinicas de Porto Alegre
in Porto Alegre, Brazil on the 16th of June, 2005.


 

August 12 2005

Itsibio, Applied Isotope Technologies and MountainTop Technologies sign agreement to explore business opportunities of mutual interest involving proteomics.


 

August 9 2005

Itsibio and Lampire Biological Laboratories, Pipersville, PA sign a three year collaboration and teaming agreement covering antibody production, bioreagent development and proteomics.


 

August 5 2005

Itsibio signs a distribution agreement with Biomedical Marketing Associates. BMA will market and distribute ITSI’s proteomics products including protein isolation, fractionation and assay kits in 5 states: Michigan, Ohio, Kentucky, West Virginia and Western Pennsylvania.



July 22 2005

David H. Fyock, Chairman/CEO, MountainTop Technologies Inc., Matt Pamuku, President, Applied Isotope Technologies, Inc., Prof. HM (Skip) Kingston, PhD, Duquesne University and Dr. Steve Ayanruoh, MD, Chairman, Ruskat Medical Equipment Corp and Applied Medical Technologies, visit Itsibio to discuss collaboration and teaming agreement.


 

July 15 2005

Stephen C. Metzger, Director Business Lending Services of Southern Allegheny Planning & Development Commission, Altoona, PA visits itsibio to discuss funding opportunities and support. SAPDC is supporting itsibio’s effort to export bioanalytical reagents produced in Johnstown, PA to Mexico and Brazil, and to access funds through the Small Business First loan program.


 

July 14 2005

D. Brian Krier (Director Business Development) and Sherry A. Davidson (Account Manager) both of The Ben Franklin Transformation Services Network, Altoona/University Park, PA visit Itsibio. Ben Franklin Technology Partners has been helping Itsibio since June of 2005 to strategize and transform our overall operations to become more efficient and competitive, both nationally and globally.


 

July 12 2005

Ed Huttenhower, Director, Small Business Development Center (SBDC)/Center for Global Competitiveness, St Francis University, Loretto, PA visits Itsibio. SBDC is helping Itsibio enter foreign markets, prepare targeted marketing materials and screen foreign companies interested in distribution of Itsibio’s protein isolation and protein assay kits in Mexico and Brazil.


July 11 2005

Prof. Francis A.A. Adeniyi, Dean, Faculty of Basic Medical Sciences and Ag. Director, Institute for Advanced Medical Research & Training (IMRAT), University of Ibadan, Ibadan, Nigeria visits itsi-Biosciences to discuss collaboration in the areas of biomedical research, bioanalytical support, tissue banking and data center development.


July 8 2005

Itsibio acquires ProteinChip System Series 4000 Enterprise Edition Surface Enhanced Laser Desorbed Ionization – Time of Flight (SELDI-Tof) from Ciphergen Biosystems as part of an emerging collaboration between Itsibio and Ciphergen. The system, which is the best for analysis of serum, plasma, urine and saliva will support internal biomarker discovery programs and will enable Itsibio to provide contract biomarker discovery services to academia and pharmaceutical industries.


 

July 7 2005

Itsibio representatives visit NCI-Frederick, Frederick MD. Present seminar “Integrating emerging high throughput technologies for complex disease research”


 

July 6 2005

Itsibio representatives visit GE Healthcare, Piscataway NJ. Meet with Andy Bertera, Head of Marketing, Gene & Protein Discovery.


 

June 20 2005

Itsibio attends Bio 2005, meets with potential partners from around the world.


 

June 17 2005

Itsibio representative visits Hospital das Clinicas de Porto Alegre, Universidade Federal do Rio Grande Sul, Porto Alegre, Brazil. Presents seminar “Advances in Tissue Banking & Biomedical Research” and meets with Prof Dr. Carlos Menke and top faculty members to discuss partnership.


 

April 19 2005

Mr. Joseph Burke, Director, Americas, So. Africa, Mid. East & Oceania Grp., PA DCED, Mr. Donald M. Bonk, International Trade Manager, SAPDC and Ms. Silvia Alonso, Senior Trade Specialist for PA in Mexico visit itsibio corporate headquarters/laboratory.


 

April 13 2005

Itsibio attends American Society of Breast Disease (ASBD) annual meeting (April 13-16 2005) in Las Vegas, NV. Itsibio representative serves on the Outreach and special populations committee and is a member of the Expert working group on risk assessment of the ASBD.


 

March 22 2005

Itsibio representative visits University of Nigeria, Nsukka, Nigeria and presents seminar “Emerging high throughput technologies and complex disease research” Meets with Director, University Resource Foundation, Provost, University of Nigeria Teaching Hospital, Chief Medical Director, University of Nigeria Teaching Hospital and other senior faculty and university administrators to discuss partnership between both organizations.


March 19 2005

Itsibio representative visits the Institute of Advanced Medical Research & Training, University of Ibadan, Nigeria and University College Hospital, Ibadan, Nigeria. Presents a seminar &;Advances in High throughput Biomedical Research & Personalized Medicine. Meets with Prof E. Bababunmi, Prof. Francis AA Adeniyi and Prof. Idowu Yinka and other senior faculty members to discuss partnership between both organizations.


 

March 18 2005

Itsibio representative attends the launching of the Nigerian Army Medical Corps/School (NAMC/S) rollback malaria program. Meets with the Honorable Minister of State for defense Dr. Roland Oritsejafor, Lt. Gen ML Agwai (Chief of Army Staff) and Maj. Gen B. E. Abang (Commandant NAMC/S).


March 4 2005

Itsibio representative visits and presents a seminar; Application of emerging high throughput technologies in complex disease research; at the College of Pharmacy, University of Houston, TX. Meets with Dean Sunny Ohia and senior faculty.


February 02 2005

Itsibio and Asterand Inc. sign collaboration agreement.


 

January 3 2005

Itsibio formally opens ultra-modern laboratory for genomics and proteomics research and provision of bioanalytical services.